Among adults with COPD and type 2 inflammation, having a history of cardiovascular or metabolic disease did not change ...
Prescribing inhalers offers physicians a chance to impact climate change — but switching to greener options comes with ...
Receiving dupilumab for 52 weeks lowered the risk for severe exacerbations vs. placebo in adults with COPD and type 2 ...
Select your location to view local American Lung Association events and news near you.
PsyPost on MSN
Early-life sugar restriction is linked to lower adult asthma and COPD risk, study finds
A new study suggests that restricting sugar intake during pregnancy and the first two years of a child’s life is associated ...
TipRanks on MSN
Sanofi’s New COPD Treatment Study: A Potential Game-Changer?
Sanofi (($SNYNF)) announced an update on their ongoing clinical study. Sanofi is conducting a study titled ‘A Phase 2b/3, Randomized, ...
AstraZeneca's hopes of a big new indication for respiratory drug Fasenra in chronic obstructive pulmonary disease (COPD) have been dashed by a negative phase 3 trial. The RESOLUTE study of IL-5 ...
News-Medical.Net on MSN
New insights explain the mechanics behind deep breaths and lung relief
More than half of all premature babies born before the 28th week of pregnancy develop respiratory distress syndrome shortly ...
Hello, and welcome to a special episode of USA TODAY's The Excerpt. I'm Dana Taylor.
President Trump has been a cheerleader for coal miners. But these miners say his administration is failing to enforce limits ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results